SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5veu'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FM6_X_BRLX504_1
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ILE A 303
PHE A 304
GLY A 306
SER A 311
LEU A 211
None
RIT  A 602 (-3.7A)
HEM  A 601 ( 3.8A)
None
None
1.00A 1fm6X-5veuA:
undetectable
1fm6X-5veuA:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_A_AG2A7005_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 6 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.89A 1mt1A-5veuA:
undetectable
1mt1F-5veuA:
undetectable
1mt1A-5veuA:
7.61
1mt1F-5veuA:
12.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_B_AG2B7001_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 6 ILE A 276
ARG A 260
ASP A 270
LEU A 269
None
0.83A 1mt1B-5veuA:
undetectable
1mt1C-5veuA:
undetectable
1mt1B-5veuA:
12.24
1mt1C-5veuA:
7.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_G_AG2G7003_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 6 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.83A 1mt1G-5veuA:
undetectable
1mt1J-5veuA:
undetectable
1mt1G-5veuA:
7.61
1mt1J-5veuA:
12.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N13_L_AG2L7014_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.89A 1n13I-5veuA:
undetectable
1n13L-5veuA:
undetectable
1n13I-5veuA:
7.61
1n13L-5veuA:
12.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1W0G_A_MYTA1499_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 6 ARG A 105
SER A 119
ILE A 301
ALA A 305
THR A 309
ALA A 370
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.69A 1w0gA-5veuA:
50.7
1w0gA-5veuA:
83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WRL_C_TFPC208_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 5 PHE A 271
LEU A 290
PHE A 189
SER A 250
None
1.29A 1wrlC-5veuA:
undetectable
1wrlC-5veuA:
13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X70_B_715B801_2
(DIPEPTIDYL PEPTIDASE
IV)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 PHE A 446
TYR A 179
TYR A 152
HEM  A 601 ( 4.9A)
None
None
0.70A 1x70B-5veuA:
undetectable
1x70B-5veuA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XWF_A_ADNA433_2
(ADENOSYLHOMOCYSTEINA
SE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 THR A 409
GLU A 362
HIS A 403
None
0.90A 1xwfA-5veuA:
undetectable
1xwfA-5veuA:
21.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ARG A 106
ALA A 305
ALA A 370
ARG A 372
GLU A 374
RIT  A 602 ( 4.0A)
HEM  A 601 (-3.4A)
RIT  A 602 (-3.3A)
None
RIT  A 602 ( 4.8A)
1.00A 2j0dA-5veuA:
50.1
2j0dA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ARG A 106
ALA A 305
THR A 309
ALA A 370
GLU A 374
RIT  A 602 ( 4.0A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
RIT  A 602 ( 4.8A)
0.92A 2j0dA-5veuA:
50.1
2j0dA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ILE A 301
ALA A 305
ALA A 370
ARG A 372
GLU A 374
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
RIT  A 602 (-3.3A)
None
RIT  A 602 ( 4.8A)
1.11A 2j0dA-5veuA:
50.1
2j0dA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ILE A 301
ALA A 305
THR A 309
ALA A 370
GLU A 374
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
RIT  A 602 ( 4.8A)
1.04A 2j0dA-5veuA:
50.1
2j0dA-5veuA:
83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_A_AG2A671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ILE A 276
ARG A 260
ASP A 270
LEU A 269
None
0.85A 2qqcB-5veuA:
undetectable
2qqcC-5veuA:
undetectable
2qqcB-5veuA:
12.66
2qqcC-5veuA:
7.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_A_AG2A672_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.81A 2qqcA-5veuA:
undetectable
2qqcF-5veuA:
undetectable
2qqcA-5veuA:
7.61
2qqcF-5veuA:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_I_AG2I671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.82A 2qqcG-5veuA:
undetectable
2qqcJ-5veuA:
undetectable
2qqcG-5veuA:
7.61
2qqcJ-5veuA:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_I_AG2I672_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.83A 2qqcI-5veuA:
undetectable
2qqcL-5veuA:
undetectable
2qqcI-5veuA:
7.61
2qqcL-5veuA:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQD_A_AG2A671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ASP A 270
LEU A 269
ILE A 276
ARG A 260
None
0.93A 2qqdA-5veuA:
undetectable
2qqdE-5veuA:
undetectable
2qqdA-5veuA:
7.40
2qqdE-5veuA:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2RLF_D_RIMD499_1
(MATRIX PROTEIN 2)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 6 ILE A 276
LEU A 261
LEU A 295
ASP A 292
None
1.06A 2rlfA-5veuA:
undetectable
2rlfD-5veuA:
undetectable
2rlfA-5veuA:
9.07
2rlfD-5veuA:
9.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 11 ARG A 105
SER A 119
ILE A 301
ALA A 305
GLU A 374
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
RIT  A 602 ( 4.8A)
None
0.67A 2v0mA-5veuA:
56.5
2v0mA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 11 ARG A 105
SER A 119
ILE A 301
PHE A 304
ALA A 305
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
None
0.73A 2v0mA-5veuA:
56.5
2v0mA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 11 PHE A 215
ARG A 105
ILE A 301
PHE A 304
ALA A 305
LEU A 481
RIT  A 602 (-4.0A)
HEM  A 601 (-2.8A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
None
1.49A 2v0mA-5veuA:
56.5
2v0mA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 11 SER A 119
ILE A 301
PHE A 304
ALA A 305
ARG A 372
LEU A 481
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
None
None
0.97A 2v0mA-5veuA:
56.5
2v0mA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
7 / 12 ARG A 105
SER A 119
PHE A 241
ILE A 301
ALA A 305
THR A 309
GLU A 374
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 ( 4.8A)
0.72A 2v0mC-5veuA:
48.7
2v0mC-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 12 SER A 119
PHE A 241
ILE A 301
ALA A 305
THR A 309
ARG A 372
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
None
0.78A 2v0mC-5veuA:
48.7
2v0mC-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
7 / 11 ARG A 105
SER A 119
ILE A 301
ALA A 305
THR A 309
GLU A 374
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 ( 4.8A)
None
0.65A 2v0mD-5veuA:
56.5
2v0mD-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
7 / 11 ARG A 105
SER A 119
ILE A 301
PHE A 304
ALA A 305
THR A 309
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
None
0.65A 2v0mD-5veuA:
56.5
2v0mD-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
7 / 11 SER A 119
ILE A 301
PHE A 304
ALA A 305
THR A 309
ARG A 372
LEU A 481
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
None
None
0.95A 2v0mD-5veuA:
56.5
2v0mD-5veuA:
83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YLO_A_TESA1920_1
(ANDROGEN RECEPTOR)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 LEU A 455
LEU A 459
GLN A 332
VAL A 327
MET A 353
None
1.43A 2yloA-5veuA:
undetectable
2yloA-5veuA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Z0A_A_GLYA73_0
(NONSTRUCTURAL
PROTEIN 1)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 5 GLN A 298
ALA A 117
ILE A 118
ARG A 439
None
None
HEM  A 601 (-4.1A)
HEM  A 601 (-3.9A)
1.31A 2z0aA-5veuA:
undetectable
2z0aA-5veuA:
10.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 5 LEU A 490
GLN A 471
THR A 470
THR A 317
None
1.20A 2zj0B-5veuA:
undetectable
2zj0B-5veuA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 4 LEU A 490
GLN A 471
THR A 470
THR A 317
None
1.32A 2zj0D-5veuA:
undetectable
2zj0D-5veuA:
22.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E4E_A_4PZA501_1
(CYTOCHROME P450 2E1)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 ALA A 305
THR A 309
CYH A 441
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
HEM  A 601 (-2.2A)
0.70A 3e4eA-5veuA:
37.4
3e4eA-5veuA:
30.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E4E_B_4PZB501_1
(CYTOCHROME P450 2E1)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 ALA A 305
THR A 309
CYH A 441
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
HEM  A 601 (-2.2A)
0.66A 3e4eB-5veuA:
37.2
3e4eB-5veuA:
30.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FSU_E_C2FE995_0
(5,10-METHYLENETETRAH
YDROFOLATE REDUCTASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 11 THR A 136
SER A 281
GLN A 279
LEU A 132
ARG A 128
None
1.48A 3fsuE-5veuA:
undetectable
3fsuE-5veuA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LCV_B_SAMB301_0
(SISOMICIN-GENTAMICIN
RESISTANCE METHYLASE
SGM)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ARG A 105
PHE A 271
SER A 188
THR A 187
ALA A 305
HEM  A 601 (-2.8A)
None
None
None
HEM  A 601 (-3.4A)
1.29A 3lcvB-5veuA:
undetectable
3lcvB-5veuA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_A_RITA600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 PHE A 215
PHE A 241
PHE A 304
ALA A 305
GLY A 480
RIT  A 602 (-4.0A)
RIT  A 602 (-3.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
RIT  A 602 ( 3.7A)
1.06A 3nxuA-5veuA:
49.3
3nxuA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_A_RITA600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 SER A 119
ILE A 301
ALA A 305
ALA A 370
GLY A 480
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
RIT  A 602 (-3.3A)
RIT  A 602 ( 3.7A)
0.87A 3nxuA-5veuA:
49.3
3nxuA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_A_RITA600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 12 SER A 119
PHE A 241
ILE A 301
PHE A 304
ALA A 305
GLY A 480
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
RIT  A 602 ( 3.7A)
0.48A 3nxuA-5veuA:
49.3
3nxuA-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_B_RITB600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 MET A 114
PHE A 215
PHE A 241
PHE A 304
ALA A 305
None
RIT  A 602 (-4.0A)
RIT  A 602 (-3.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
0.77A 3nxuB-5veuA:
48.9
3nxuB-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_B_RITB600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 MET A 114
SER A 119
ILE A 301
ALA A 305
ALA A 370
None
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
RIT  A 602 (-3.3A)
0.73A 3nxuB-5veuA:
48.9
3nxuB-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_B_RITB600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
6 / 12 MET A 114
SER A 119
PHE A 241
ILE A 301
PHE A 304
ALA A 305
None
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
0.41A 3nxuB-5veuA:
48.9
3nxuB-5veuA:
83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NXU_B_RITB600_2
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 9 ARG A 105
THR A 309
LEU A 373
GLU A 374
GLY A 480
HEM  A 601 (-2.8A)
HEM  A 601 ( 3.5A)
HEM  A 601 ( 4.2A)
RIT  A 602 ( 4.8A)
RIT  A 602 ( 3.7A)
0.85A 3nxuB-5veuA:
48.9
3nxuB-5veuA:
83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_H_CLMH221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 SER A 180
LEU A 160
VAL A 492
PHE A 464
VAL A 458
None
1.41A 3u9fH-5veuA:
undetectable
3u9fI-5veuA:
undetectable
3u9fH-5veuA:
17.43
3u9fI-5veuA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_P_CLMP221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 9 SER A 180
LEU A 160
VAL A 492
PHE A 464
VAL A 458
None
1.49A 3u9fP-5veuA:
undetectable
3u9fP-5veuA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_R_CLMR221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 10 SER A 180
LEU A 160
VAL A 492
PHE A 464
VAL A 458
None
1.49A 3u9fR-5veuA:
undetectable
3u9fR-5veuA:
17.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UA1_A_08YA600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ARG A 105
ARG A 106
ALA A 305
THR A 309
ALA A 370
HEM  A 601 (-2.8A)
RIT  A 602 ( 4.0A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.92A 3ua1A-5veuA:
52.7
3ua1A-5veuA:
83.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UA1_A_08YA600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ARG A 105
SER A 119
ALA A 305
THR A 309
ALA A 370
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.89A 3ua1A-5veuA:
52.7
3ua1A-5veuA:
83.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UA1_A_08YA600_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 ARG A 106
PHE A 304
ALA A 305
THR A 309
ALA A 370
RIT  A 602 ( 4.0A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
1.07A 3ua1A-5veuA:
52.7
3ua1A-5veuA:
83.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LRH_B_FOLB301_1
(FOLATE RECEPTOR
ALPHA)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 ASP A 424
TRP A 408
SER A 420
None
1.01A 4lrhB-5veuA:
undetectable
4lrhB-5veuA:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LRH_F_FOLF301_1
(FOLATE RECEPTOR
ALPHA)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 ASP A 424
TRP A 408
SER A 420
None
1.00A 4lrhF-5veuA:
undetectable
4lrhF-5veuA:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUM_A_IMNA501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 PHE A 316
HIS A 403
LEU A 476
LEU A 482
TYR A 399
None
1.32A 4xumA-5veuA:
2.0
4xumA-5veuA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKT_A_TLFA601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
3 / 3 LEU A 211
TYR A 307
SER A 312
None
0.90A 5iktA-5veuA:
0.9
5iktA-5veuA:
23.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5TE8_B_08JB602_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 8 ARG A 105
ALA A 305
ALA A 370
LEU A 481
HEM  A 601 (-2.8A)
HEM  A 601 (-3.4A)
RIT  A 602 (-3.3A)
None
0.71A 5te8B-5veuA:
26.1
5te8B-5veuA:
83.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5TE8_B_08JB602_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 8 ARG A 105
SER A 119
ALA A 370
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 (-3.3A)
None
0.80A 5te8B-5veuA:
26.1
5te8B-5veuA:
83.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VCE_A_RITA602_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
7 / 12 SER A 119
PHE A 241
ILE A 301
PHE A 304
ALA A 305
THR A 309
ALA A 370
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.74A 5vceA-5veuA:
53.9
5vceA-5veuA:
82.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VCG_A_08YA602_1
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 PHE A 304
ALA A 305
THR A 309
ALA A 370
GLU A 374
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
RIT  A 602 ( 4.8A)
1.05A 5vcgA-5veuA:
52.9
5vcgA-5veuA:
82.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BRD_A_RFPA502_1
(RIFAMPIN
MONOOXYGENASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 12 VAL A 183
PHE A 446
LEU A 481
VAL A 369
GLY A 443
None
HEM  A 601 ( 4.9A)
None
HEM  A 601 ( 4.9A)
HEM  A 601 ( 4.0A)
1.39A 6brdA-5veuA:
undetectable
6brdA-5veuA:
11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GTQ_B_ACTB207_0
(DUF1778
DOMAIN-CONTAINING
PROTEIN
N-ACETYLTRANSFERASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 6 LEU A 272
GLY A 190
ARG A 260
ARG A 268
None
1.34A 6gtqB-5veuA:
undetectable
6gtqD-5veuA:
undetectable
6gtqB-5veuA:
18.11
6gtqD-5veuA:
7.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H1L_A_FJQA501_0
(BIFUNCTIONAL
CYTOCHROME
P450/NADPH--P450
REDUCTASE)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 10 LEU A 236
VAL A 238
VAL A 232
ILE A 223
LEU A 219
None
1.31A 6h1lA-5veuA:
38.2
6h1lA-5veuA:
29.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MA6_A_MYTA603_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
5 / 6 ARG A 105
SER A 119
ALA A 305
THR A 309
ALA A 370
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.75A 6ma6A-5veuA:
52.3
6ma6A-5veuA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MA7_A_TPFA602_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ARG A 105
ALA A 305
THR A 309
ALA A 370
HEM  A 601 (-2.8A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.70A 6ma7A-5veuA:
52.0
6ma7A-5veuA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MA7_A_TPFA602_0
(CYTOCHROME P450 3A4)
5veu CYTOCHROME P450 3A5
(Homo
sapiens)
4 / 7 ARG A 105
SER A 119
THR A 309
ALA A 370
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
HEM  A 601 ( 3.5A)
RIT  A 602 (-3.3A)
0.66A 6ma7A-5veuA:
52.0
6ma7A-5veuA:
76.25